Ultralife (ULBI) Shares Outstanding (Weighted Average) (2016 - 2025)
Ultralife has reported Shares Outstanding (Weighted Average) over the past 16 years, most recently at $16.6 million for Q4 2025.
- Quarterly results put Shares Outstanding (Weighted Average) at $16.6 million for Q4 2025, up 0.53% from a year ago — trailing twelve months through Dec 2025 was $16.6 million (up 0.53% YoY), and the annual figure for FY2025 was $16.6 million, up 0.53%.
- Shares Outstanding (Weighted Average) for Q4 2025 was $16.6 million at Ultralife, roughly flat from $16.6 million in the prior quarter.
- Over the last five years, Shares Outstanding (Weighted Average) for ULBI hit a ceiling of $16.6 million in Q3 2025 and a floor of $16.0 million in Q1 2021.
- Median Shares Outstanding (Weighted Average) over the past 5 years was $16.2 million (2023), compared with a mean of $16.3 million.
- Biggest five-year swings in Shares Outstanding (Weighted Average): skyrocketed 100748.95% in 2021 and later increased 0.14% in 2023.
- Ultralife's Shares Outstanding (Weighted Average) stood at $16.0 million in 2021, then grew by 0.53% to $16.1 million in 2022, then increased by 0.57% to $16.2 million in 2023, then rose by 2.1% to $16.6 million in 2024, then grew by 0.53% to $16.6 million in 2025.
- The last three reported values for Shares Outstanding (Weighted Average) were $16.6 million (Q4 2025), $16.6 million (Q3 2025), and $16.6 million (Q2 2025) per Business Quant data.